To document the in vivo interactions occurring between the immune system and HIV replicating cells, we analyzed using in situ hybridization the production of IL-1#, and INF-y in eight hyperplastic lymph nodes from HIV-1 infected patients. Numerous IL-1ft-and IL-6-producing cells associated in clusters were detected in sinuses. Few individual IL-1l#-and IL-6-producing cells were present in interfollicular and follicular areas. IL-2-and INF-'y-producing cells were observed in all lymph node compartments, with a selective enrichment in germinal centers. The amount and distribution of
Introduction
HIV infection leads to an acquired immunodeficiency syndrome mainly characterized by an unusual sensitivity to opportunistic infectious agents. However, the interval of time between the initial infection and the development of this immunodeficiency state can span several years. The mechanisms of transition from the asymptomatic state to immunodeficiency are only partially understood (reviewed in [1] [2] [3] . The spread of HIV infection may be dependent on the rate of HIV replication as well as on stimulations ofthe immune system or coinfection with non-HIV viruses. In contrast, selective destruction of HIV replicating cells by the immune system may limit the progression of the disease. This anti-HIV immune response may also destroy uninfected cells coated with viral antigens (2, 4, 5) . This latter phenomenon could at least partially explain the dramatic decrease in CD4+ T lymphocytes levels observed in the latest stages of the disease, and which play a pivotal role in the appearance of the immune defect.
Given the potential role of the immune system in both HIV infection control and HIV induced immune defect, the in vivo interactions between HIV replicating cells and immune cells should be defined. To this end, we analyzed using in situ hybridization the production of cytokines in lymph nodes from patients presenting persistent generalized lymphadenopathies (PGL) .' This synthesis of interleukins was compared to that of reactive lymph nodes from non-HIV-infected patients to define HIV-specific events.
Methods
Patients. Eight biopsy specimens from HIV-1 infected patients were included in this study. Two tissue samples (la and lb) obtained at 6-mo intervals were available for patient 1. The diagnosis of HIV-1 infection was ascertained by the demonstration ofanti-HIV-l antibodies in two different serum samples using an ELISA immunoassay, and confirmed by Western blot analysis. The main clinical characteristics and laboratory findings of these patients at the moment of the biopsy are summarized in Table I . All of them exhibited PGL. Patients 3 and 7 presented a Kaposi sarcoma that did not involve lymph nodes. None of the seven patients presented opportunistic infection and only patient 3 had a major CD4+ T cell depletion. Serological analysis for anti-HTLV-l antibodies was negative in the four patients tested (patients 1, 2, 5, and 6, thus including the three patients contaminated by intravenous drug abuse). There was no clinical or geographical argument suggesting an HTLV-l coinfection in the three remaining patients.
As controls, six patients presenting lymph node enlargements of unknown origin without any evidence of HIV infection (including serological analysis) were studied.
Tissues. Lymph nodes were obtained at surgical biopsy. A portion of each specimen was immediately frozen in liquid nitrogen and stored at -80°. In all cases tissue samples were also fixed in neutral formalin and processed for histological examination. Histological changes suggesting mycobacterial, herpes simplex virus, cytomegalovirus (CMV), or EBV infection (6) were observed in none of the tissue samples.
Detection of viral replication. Several approaches were performed to document viral replication in the lymph nodes studied. The detection of viral antigens was realized by immunohistochemistry using a three-step immunoperoxidase technique (7) . The presence of HIV antigens was analyzed using an anti-p24 monoclonal antibody (clone 1 HIV, final dilution 1/75) (Biosoft, Paris, France). HIV-1 replication was also analyzed using in situ hybridization (see below). HSV 1 or 2 infection was assessed using an anti-HSV 1 + 2 monoclonal antibody (clone CHA 437, final dilution: 1/400) (Biosoft). A lymph node exhibiting typical histological features of HSV infection was used as positive control. Detection of CMV antigens was performed using an anti-CMV early antigen monoclonal antibody (clone E13, final dilution: 1/100; Biosoft). CMV replicating cultured fibroblasts were anal. Abbreviations used in this paper: CMV, cytomegalovirus; PGL, persistent generalized lymphadenopathies. Probes. The IL-lIW probe corresponded to the Pst-l-Acc-l 920 bp long fragment ofthe human IL-1,I cDNA (9) cloned in the Pst-l-Acc-l restriction sites ofT3-T7 Bluescript plasmid (Stratagene, La Jolla, CA). The IL-2 probe was as previously described (10) . The IL-6 probe corresponded to the Xba I-Eco RI 517-bp long fragment of the human IL-6 cDNA cloned in the Xba 1-Eco RI sites of T3-T7 Bluescript plasmid. The INF--y probe corresponded to the Hinf l-Pst 1 540-bp long fragment of the human INF-y cDNA (11) cloned in the Bam HI -Pst 1 sites of T3-T7 Bluescript plasmid. The HIV-I specific probe corresponded to the gag coding sequences of HIV-1 present in a Hind 3-Pst 1 DNA fragment (from bp 75 to bp 995) (12) . For each probe, anti-sense and sense "IS-labeled probes were synthesized using T3 or T7 polymerase according to manufacturer recommendations (Stratagene). The sense probe was used as control in each experiment and gave no positive signal (data not shown).
Hybridization procedure and combination ofimmunohistochemistry and in situ hybridization. They were performed as previously described (10 To determine the proportion of IL-2-or INF-y-producing cells among CD3+ cells in the different lymph node compartments (follicular or interfollicular areas), we used a grid according to Garcia et al. (13) . We counted for each compartment and in three serial sections the total number of IL-2-producing cells, the total number of INF-y-producing cells, the total surface and the total CD3+ cell count, respectively. The proportion oflymphokine producing cells corresponded to the ratio between the total number oflymphokine-producing cells and that of CD3+ cells. Results expressed represent the mean number (±SEM) oflymphokine producing cells/104 T cells. A paired Student's t test was used for statistical analysis.
Results
Detection ofHIV-I antigens and HIV-J RNA in HIV-J lymph nodes. To detect the presence of HIV-1 antigens, immunostaining using an anti-p24 antibody was performed on both HIV-l and non-HIV lymph nodes. No staining was observed in the latter (Fig. 1 A) . In contrast, all HIV-1 lymph nodes exhibited a clear staining of germinal centers ( Fig. 1 C) . The reticular pattern of positivity observed suggested that the labeled cells were reticular dendritic cells.
When performing in situ hybridization experiments using an HIV-I gag specific probe, two different patterns of hybridization were observed according to exposure time in all HIV-l lymph nodes. After 4 d exposure, very rare positive cells were detected. They were located either in follicles or in interfollicular areas (not shown). When exposure was prolonged until day 20, germinal centers from all HIV infected lymph nodes were stained with the HIV-l specific probe (Fig. 1 D) . As for p24 antigen expression, this labeling was diffusely distributed throughout follicles. No additional cells were detected in interfollicular areas as compared to tissue sections exposed for 4 d. No labeling of non-HIV lymph nodes was observed, regardless of time exposure (Fig. 1 B) .
To document a possible coinfection of HIV lymph nodes with non-HIV viruses, we performed several experiments. We first looked for the presence of herpes virus antigens by immunohistochemistry. No staining was observed in any HIV lymph node when using either an anti-HSV 1 and 2, an anti-CMV, or an anti-EBV monoclonal antibody. It should be pointed out that one ofthe non-HIV lymph nodes (patient 10) was positively stained with the anti-EBV MAb (not shown). The absence of CMV coinfection in HIV lymph nodes was confirmed by the negativity of CMV cultures of these tissue sections. It must also be stressed that none of the lymph node from HIV infected patients displayed histological changes sug- trabecular sinuses where they were distributed in clusters (Fig.  2 A) . Few individual positive cells were also detected in lower amounts in follicular and interfollicular areas. There was no diffuse labeling of germinal centers.
The number and location of IL-6 producing cells were identical to those of IL-1I# producing cells: most cells labeled with the IL-6 probe were associated in clusters within sinuses (Fig. 2 B) , with few solitary cells present in follicles and interfollicular areas. These IL-lI# and IL-6 producing cells displayed a large cell size and were present in the lumen as well as in the wall of sinuses (Fig. 2, C and D) . Therefore, both location and size of IL-lI3 and IL-6 producing cells suggested their macrophage-histiocyte lineage. These IL-I# and IL-6 productions were not restricted to HIV hyperplastic lymph nodes, as they were detected in similar amount and distribution in lymph node sections from six patients presenting a non-HIV-related follicular hyperplasia (not shown).
IL-2 and INF-,y production in HIV-I lymph nodes. To analyze the production of IL-2 and INF-'y in HIV replicating lymph nodes, we hybridized sections from the eight HIV lymph nodes with an IL-2 and an INF--y specific probe. We detected both IL-2-and INF-y-producing cells in these lymph nodes (Fig. 3) . These lymphokine-producing cells were scattered in follicular and interfollicular areas. We observed a similarly located IL-2 and INF--y synthesis in the six non-HIV hyperplastic lymph nodes (see Fig. 4 and Table II) .
To quantitate the level of lymphokine production, we determined the density of IL-2-and INF-y-producing cells in the different lymph nodes. To this end, we analyzed the number of lymphokine-producing cells and the surface of the corresponding lymph node section. HIV and non-HIV sections were studied in parallel as detailed in Methods. Two main observations could be drawn from these results (Fig. 4) . First, the density of IL-2-producing cells was in the same range in HIV and in non-HIV lymph nodes: as a mean there were 2.7 times less IL-2 producing cells in HIV than in non-HIV lymph nodes, this difference being not statistically significant. shows that, at least in HIV patients presenting PGL, the production of IL-2 in a lymphoid organ is not dramatically affected by the replication of HIV at this site. We examined whether the two contrasting histological patterns (florid hyperplasia and follicle lysis) of HIV lymph nodes could be related to the INF-y/IL-2 ratio. Interestingly, the two HIV lymph nodes in which the INF-'y/IL-2 ratio was the lowest (patients 6 and 7, ratio = 2.8 and 0.9, respectively) displayed an histological pattern offollicle lysis. A third case of follicle lysis (patient 5) exhibited a high INF-"y/IL-2 ratio, to the same extent as the other five lymph nodes that exhibited florid hyperplasia. This suggests that the enrichment in INF-y producing cells may be weak or absent in some lymph nodes showing follicle lysis, an histological pattern that may represent a subsequent step of follicle evolution following florid hyperplasia (14) .
Therefore, the quantitative evaluation of lymphokine-producing cells showed that the presence of HIV in hyperplastic lymph nodes was associated with the production of both IL-2 and INF-Ey with a preferential synthesis of the latter interleukin.
Localization ofIL-2 and INF-y production. We next studied the fine distribution of lymphokine producing cells in the different lymph node compartments. This approach may be indicative ofthe site ofT cell activation in these tissues. In this purpose, we determined in the different compartments of 3 serial sections the number of IL-2 and INF-y producing cells and that of CD3+ cells (Table II) . We evidenced a selective enrichment of lymphokine-producing cells in follicles as compared to interfollicular areas. The higher proportion of and IFN-'y synthetizing T &lls in follicles was observed in both HIV and non-HIV lymph nodes. Therefore, germinal centers may be the preferential site ofT cell activation regardless ofthe nature of the stimulant. This could be related to the function of follicular dendritic cells as antigen-presenting cells.
Characterization ofINF-y-producing cells. From the previous results, it appears that the immune reaction induced by HIV replication in hyperplastic lymph nodes is characterized by an increased level of INF-Ey production. As infiltration of germinal centers with CD8+ cells is known to be a specific feature of HIV replicating lymph nodes (reviewed in 14) , we wished to determine whether this high level of INF--y production arose from this T cell subpopulation. When simultaneously analyzing the presence of CD8 antigens and of INF-,y mRNA containing cells by combining immunohistochemistry and in situ hybridization, we observed that many germinal center infiltrating CD8+ cells indeed produced INF-Ey (Fig; 5) . Thus, the elevated INF-'y production observed in HIV lymph nodes is at least partially related to the specific CD8+ infiltra- 
Discussion
In the present work we studied using in situ hybridization the production of interleukins in hyperplastic lymph nodes from HIV-l infected patients presenting PGL. We compared these productions with those observed in non-HIV-related hyperplastic lymph nodes.
When analyzing the in situ production of IL-lIB and IL-6 in HIV lymph nodes, we observed a high number of IL-1,8-and IL-6-producing cells, essentially located in clusters within sinuses. Very few scattered individual cells were observed in follicles and interfollicular areas. The distribution and the apparent size of these IL-lI#-and IL-6-producing cells suggest their macrophage-histiocyte origin. As monocytoid cells expressing B lymphocyte antigens have recently been identified in sinuses of hyperplastic lymph nodes (15, 16), we cannot formally exclude that the IL-13 and IL-6 productions we detected arose from this cell population. However, it should be stressed that cells hybridizing with the IL-lI# or the IL-6 probe were rarely found in germinal centers, an area that is mainly constituted of activated B lymphocytes and reticular dendritic cells. This indicates that the production of IL-I, and IL-6 by these latter cell populations, if any, must be marginal. The presence of positive cells in the wall ofthe sinuses also suggests that sinus endothelial cells may participate to this IL-1# and IL-6 production. To our knowledge no report is presently available regarding the in situ production of cytokines in non-HIV hyperplastic lymph nodes. The amount and location of IL-1I -and IL-6-producing cells we detected in these tissues was strikingly similar to that observed in HIV lymph nodes. The production of monokines (as well as the hyperplastic pattern ofthe lymph nodes) is suggestive ofan immune activation ofthese lymphoid organs, which is probably directly related to the presence of HIV in the case of HIV-replicating lymph nodes. Indeed we found no evidence of coinfection of these latters with non-HIV viruses. HIV has been shown to stimulate the in vitro production of IL-1 and IL-6 (17, 18) , and a similar phenomenon probably occurs in vivo, as unstimulated purified blood monocytes from HIV-infected patients produce increased levels of IL-I (19) .
We also detected IL-2-producing cells in HIV lymph nodes. These cells were located both in follicular and interfollicular areas. They were present in low amounts, in the range of 1 to 7 IL-2 producing cells/104 CD3+ cells. This IL-2 production can be ascribed to T cell activation for the following reasons: (a) such an IL-2 production is virtually absent in normal thymus sections (Emilie, D., et al., submitted for publication) (b) the density of IL-2 producing cells in HIV lymph nodes is in the same range of that found in lymphoid organs involved in an immune reaction, including non-HIV hyperplastic lymph nodes (this work), tumor-induced immune response (10, 19a) or hyperplastic thymuses from myasthenic patients (Emilie, D., et al., submitted for publication). The detection of virtually normal amounts of IL-2-producing cells in HIV lymph nodes contrasts with results obtained from previous studies that showed a profound impairment in the ability of in vitro activated peripheral blood lymphocytes from HIV patients to produce IL-2 (20) (21) (22) (23) (24) . However, this decreased production of IL-2 is no more found when studied at the cellular subset level (24) . Moreover, in vitro HIV infected cell lines constitutively transcribe IL-2 gene and produce increased levels of IL-2 mRNA when stimulated in vitro with a mitogen (25) . It should also be noted that none ofthe patients analyzed in this study displayed a profound immune defect, as none of them presented opportunistic infection and only one had a major circulating CD4+ T cell depletion. Finally, the absence of IL-2 production impairment in PGL presenting patients may be explained by the fact that the production of IL-2 (a lymphocyte growth factor) may be required for the development of lymph node hyperplasia, which does not occur in all HIV patients and usually disappears in the latest stage of the disease. Taken together, we conclude that HIV-1 replication by itself does not inhibit IL-2 production in vivo, at least in patients exhibiting PGL.
HIV lymph nodes displayed numerous INF-y mRNA containing cells. This result contrasts with reports ofdecreased in vitro production of this interleukin by unfractionated mononuclear cells from HIV-infected patients (24, 26) . However, as for IL-2 synthesis, this INF-y production impairment is not found when the production of cellular subsets is analyzed (24). Although we cannot exclude a dissociation (not described yet) between the production of INF-'y mRNA and that of the corresponding protein, our results strongly suggest that the in vivo synthesis of INF-Iy is conserved in HIV patients presenting PGL. This may be directly related to their preserved IL-2 production, as IL-2 can stimulate the in vitro synthesis of INF-Iy by peripheral blood lymphocytes from normal (27) and AIDS (23) subjects. Moreover infusion of IL-2 induces the appearance of circulating INF--y in AIDS patients (28) .
Quantitative analysis indicated that the amount of INF--y producing cells was in fact increased in most HIV lymph nodes when compared with that of IL-2-producing cells. This contrasted with results from non-HIV lymph nodes in which the number of INF--y-producing cells was similar to that of IL-2-producing cells. The present results can also be compared with those from our recent study of 21 follicular lymphomas (1 9a). In this study we found that the mean number of IL-2-producing cells was higher than that of INF-,y producing cells (the ratio between IL-2 and INF-y producing cells was 2.69±0.84). These data underline the peculiar pattern observed in HIV lymph nodes. Thus distinct patterns of interleukin production by activated T cells may occur in different in vivo situations, HIV preferentially stimulating INF-'y production.
Germinal centers may be considered as a critical site for the interactions between HIV and the host immune system. They contain high amounts of HIV core antigens, as evidenced in several studies by the positivity of immunolabeling with anti-HIV core antibodies (14, (29) (30) (31) (32) (33) (34) (35) and this work). The reticular pattern ofanti-p24 staining indicates that the network offollicular dendritic cells may be an important reservoir of HIV antigens at this site. This is supported by electron microscopy studies in which HIV particles were only found in germinal centers, in close contact with processes of follicular dendritic cells (31, [36] [37] [38] [39] . When performing in situ hybridization we observed two kinds of labeling. Very rare HIV RNA containing cells located both in follicles and in interfollicular areas were detected after short exposure time, as already reported in similar conditions or when using nonradioactive probes (29, 35, 40, 41) . A diffuse labeling ofgerminal centers could also be evidenced in our hands provided that exposure time was prolonged. Such a delayed positivity of germinal centers has already been noted by Biberfeld et al. (40) . The pattern observed in this latter case is suggestive of follicular dendritic cell labeling (14, 40) . It may be relevant to either HIV replication in this cell population or to a viral trapping. Taken together, these different approaches indicate that germinal centers represent the major lymph node compartment containing HIV antigens, RNA, and particles.
Follicles of HIV replicating lymph nodes are infiltrated with high numbers of CD8+ cells (reviewed in 14) . As freshly isolated anti-HIV CTL from HIV-infected patients are essentially contained in this CD8+ cell subset (42) (43) (44) (45) (46) , CD8+ cells present in germinal centers may be involved in an anti-HIV cytotoxic T cell response. However no direct evaluation of their function has been performed so far. We here show that IFN-y production may be an important functional characteristic of these cells. CD8+ cells have recently been shown to inhibit the in vitro replication ofHIV upon direct contact with virus replicating cells (45, 47) , and INF-7 production may be involved in this phenomenon (48) . Our present report is the first direct demonstration that the partners for such an interaction (HIV containing dendritic cells and IFN-'y producing CD8+ cells) are present within germinal centers of HIV hyperplastic lymph nodes. Larger studies are required to determine whether the pattern of cytokine production in HIV lymph nodes is a critical factor in the course of the disease leading to the relative control of viral replication, to the development offollicle lysis and that ofmajor immune dysfunction.
